Recent advances in therapies for primary myelofibrosis

Recent advances in therapies for primary myelofibrosis

Primary myelofibrosis (PMF), polycythemia vera (PV) and essential thrombocythemia (ET) form the classical BCR-ABL1-negative myeloproliferative neoplasms (MPNs) that are driven by a constitutive activation of JAK2 signaling. PMF as well as secondary MF (post-ET and post-PV MF) are the most aggressive...

書誌詳細
主要な著者:	Vainchenker, W, Yahmi, N, Havelange, V, Marty, C, Plo, I, Constantinescu, SN
フォーマット:	Journal article
言語:	English
出版事項:	Faculty Opinions 2023

類似資料

Recent advances in understanding myelofibrosis and essential thrombocythemia [version 1; referees: 2 approved]
著者:: William Vainchenker, 等
出版事項: (2016-04-01)

Therapeutic activity of GARP:TGF-β1 blockade in murine primary myelofibrosis
著者:: Lecomte, S, 等
出版事項: (2023)

ADVANCED THERAPY IN PATIENTS WITH PRIMARY AND POSTPOLYCYTHEMIC MYELOFIBROSIS
著者:: A. N. Alekseeva, 等
出版事項: (2017-07-01)

Molecular pathogenesis of myeloproliferative neoplasms: Where do we stand in 2023?
著者:: Havelange, V, 等
出版事項: (2023)

Recent developments in myelofibrosis
著者:: Mesa RA, 等
出版事項: (2012-07-01)

SRSF2-P95H decreases JAK/STAT signaling in hematopoietic cells and delays myelofibrosis development in mice
著者:: Willekens, C, 等
出版事項: (2023)

Updated recommendations on the use of ruxolitinib for the treatment of myelofibrosis
著者:: Timothy Devos, 等
出版事項: (2022-01-01)

Primary myelofibrosis L.
著者:: L. M. Meshcheryakova, 等
出版事項: (2014-07-01)

Primary myelofibrosis L.
著者:: L. M. Meshcheryakova, 等
出版事項: (2014-07-01)

Primary myelofibrosis in rheumatic diseases
著者:: Vladimir Ivanovich Vasilyev, 等
出版事項: (2013-04-01)

JAK inhibitors for the treatment of myeloproliferative neoplasms and other disorders [version 1; referees: 2 approved]
著者:: William Vainchenker, 等
出版事項: (2018-01-01)

Treatment of primary myelofibrosis
著者:: Şinasi Özsoylu
出版事項: (2009-12-01)

Editorial: recent advances in molecular and structural endocrinology
著者:: De Meyts, P, 等
出版事項: (2023)

Advances in management of primary myelofibrosis and polycythaemia vera: Implications in clinical practice
著者:: Shanti Amé, 等
出版事項: (2023-08-01)

Hemostasis in patients with primary myelofibrosis treated with ruxolitinib
著者:: O. G. Golovina, 等
出版事項: (2024-11-01)

A phase II study of vorinostat (MK-0683) in patients with primary myelofibrosis and post-polycythemia vera myelofibrosis
著者:: Christen L. Andersen, 等
出版事項: (2014-01-01)

IRON CHELATION THERAPY WITH DEFERASIROX IN THE MANAGEMENT OF IRON OVERLOAD IN PRIMARY MYELOFIBROSIS
著者:: Elena Maria Elli, 等
出版事項: (2014-05-01)

Evidence for prevention of renal dysfunction associated with primary myelofibrosis by cytoreductive therapy
著者:: Yasutaka Fukuda, 等
出版事項: (2019-11-01)

Mutational spectrum defines primary and secondary myelofibrosis
著者:: Ken I. Mills, 等
出版事項: (2014-01-01)

Splenic Marginal Zone Lymphoma with Prominent Myelofibrosis Mimicking Triple-Negative Primary Myelofibrosis
著者:: Miyuki Tsutsui, 等
出版事項: (2019-11-01)

Possibilities of targeted therapy for myelofibrosis: Moscow experience
著者:: O. Yu. Vinogradova, 等
出版事項: (2022-11-01)

CD146+ bone marrow osteoprogenitors increase in the advanced stages of primary myelofibrosis
著者:: Claudio Tripodo, 等
出版事項: (2009-01-01)

Targeted deep sequencing in primary myelofibrosis
著者:: Ayalew Tefferi, 等
出版事項: (2016-12-01)

Calreticulin mutations in Chinese with primary myelofibrosis
著者:: Bing Li, 等
出版事項: (2014-11-01)

Is it primary myelofibrosis or chronic megakaryocytic leukemia?
著者:: Marshall A. Lichtman
出版事項: (2022-03-01)

Focus on Osteosclerotic Progression in Primary Myelofibrosis
著者:: Mariarita Spampinato, 等
出版事項: (2021-01-01)

Primary Myelofibrosis with Mesenteric Extramedullary Haematopoiesis
著者:: Saurabh Kumar, 等
出版事項: (2018-12-01)

Primary myelofibrosis: current therapeutic options
著者:: Paula de Melo Campos

Myelofibrosis and Pancytopenia Associated With Primary Hyperparathyroidism
著者:: Remya Rajan, MD, 等
出版事項: (2021-01-01)

Does angiogenesis matter in primary myelofibrosis?
著者:: Paulo Vidal Campregher
出版事項: (2014-10-01)

Patients with primary myelofibrosis: treatment and quality of life
著者:: L. M. Meshcheryakova, 等
出版事項: (2014-07-01)

Patients with primary myelofibrosis: treatment and quality of life
著者:: L. M. Meshcheryakova, 等
出版事項: (2014-07-01)

Advances in myelofibrosis: a clinical case approach
著者:: John O. Mascarenhas, 等
出版事項: (2013-10-01)

Long-term results of splenectomy in primary myelofibrosis
著者:: L. M. Meshcheryakova, 等
出版事項: (2014-07-01)

Long-term results of splenectomy in primary myelofibrosis
著者:: L. M. Meshcheryakova, 等
出版事項: (2014-07-01)

P1047: REAL-WORLD SAFETY OF RUXOLITINIB IN PATIENTS WITH INTERMEDIATE OR HIGH RISK OF PRIMARY MYELOFIBROSIS, POST-POLYCYTHEMIA VERA MYELOFIBROSIS OR POST-ESSENTIAL THROMBOCYTHEMIA MYELOFIBROSIS IN CHINA
著者:: Z. Xu, 等
出版事項: (2022-06-01)

Evidence that prefibrotic myelofibrosis is aligned along a clinical and biological continuum featuring primary myelofibrosis.
著者:: Giovanni Barosi, 等
出版事項: (2012-01-01)

Genetic Alterations of the Thrombopoietin/MPL/JAK2 Axis Impacting Megakaryopoiesis
著者:: Isabelle Plo, 等
出版事項: (2017-09-01)

PB2173: THE EFFECT OF RUXOLITINIB THERAPY ON HEMOSTATIC PARAMETERS IN PATIENTS WITH PRIMARY MYELOFIBROSIS
著者:: Natalia Korsakova, 等
出版事項: (2023-08-01)

P1015: THE EFFECT OF THERAPY ON THE COAGULATION ACTIVITY OF MICROPARTICLES IN PATIENTS WITH PRIMARY MYELOFIBROSIS
著者:: Natalia Silina, 等
出版事項: (2023-08-01)